Your GLP-1 prescription qualifies when it is treating one of these documented conditions: Type 2 diabetes Clinical obesity with a comorbidity (hypertension, sleep apnea, cardiovascular disease, or high cholesterol) Prediabetes or insulin resistance Polycystic ovary syndrome (PCOS) Non-alcoholic fatty liver disease (NAFLD) The critical requirement is documentation
In one rabbit study, it improved wound contraction and formation of granular tissue, boosted antioxidant enzymes, and stimulated blood vessel development and growth
Gastrointestinal Infections Infections caused by bacteria, viruses, or parasites can cause inflammation and bleeding in the digestive tract
However, SCD is generally less severe and easier to manage than PCD because the blood levels of carnitine are relatively higher
Long-Term Safety Considerations Need for adolescent-specific trials: Most data come from adult studies, and pediatric safety remains underexplored